Seoul, Seoul-t'ukpyolsi, South Korea Related Funds
Funds with similar focus
| Fund Name | Location |
| Blue Cross of Idaho | Idaho, Meridian, United States |
| Cahill Goron &Reindel | New York, New York, United States |
| Cowles Company | Spokane, United States, Washington |
| Gentosha Total Asset Consulting | Japan, Tokyo |
| Globe Advisors | Chiyoda, Japan |
| Gryphon Capital | Roanoke, United States, Virginia |
| GSI Commerce | King Of Prussia, Pennsylvania, United States |
| Kuo Sharper Fund | - |
| Opdorp Finance BVBA | - |
| Xiuneng Capital | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Fly Doctor | 26 Aug 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | |||
SSEM | $4M | 29 Apr 2024 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | ||
Dencom | $8M | 22 Feb 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
JLT | $2M | 08 Feb 2024 | Seongnam, Kyonggi-do, South Korea | ||
NEUROPHET | $17M | 07 Nov 2023 | South Korea, Gyeonggi-do, South Korea | ||
Eight Tech | $7M | 02 Nov 2023 | South Korea, Gangwon-do, South Korea | ||
Quad Miners | $13M | 29 Oct 2023 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | ||
Luten Technologies | $13M | 16 Jun 2023 | - | ||
HAII | $6M | 23 Nov 2022 | Seoul, Seoul-t'ukpyolsi, South Korea |
– PharmCADD announced that it has finished USD 16m series B funding on March 31, 2021.
– This funding round was led by Strategic Investors: Huons, Samyang Holdings and SD BIOSENSOR; and Financial Investors: KTB Network, Daily Partners, DSC Investment, KDB Capital, Maple Investment and KB Securities.
– As a result, PharmCADD has secured total of USD 22m in funding since its establishment.
– PharmCADD plans to use the funding not only to launch the U.S. and India-based branches but also to advance its AI & Physics-based drug discovery platform technology, Pharmulator™, and to expand R&D manpower. The funding will be used for the preclinical study of internal pipelines as well.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Fly Doctor | 26 Aug 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | |||
SSEM | $4M | 29 Apr 2024 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | ||
Dencom | $8M | 22 Feb 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
JLT | $2M | 08 Feb 2024 | Seongnam, Kyonggi-do, South Korea | ||
NEUROPHET | $17M | 07 Nov 2023 | South Korea, Gyeonggi-do, South Korea | ||
Eight Tech | $7M | 02 Nov 2023 | South Korea, Gangwon-do, South Korea | ||
Quad Miners | $13M | 29 Oct 2023 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | ||
Luten Technologies | $13M | 16 Jun 2023 | - | ||
HAII | $6M | 23 Nov 2022 | Seoul, Seoul-t'ukpyolsi, South Korea |
